Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research

Dartmouth Center of Cancer Nanotechnology Excellence
Dartmouth College

Center Investigators

Ian Baker, D.Phil.
Principal Investigator


Keith Paulsen, Ph.D.
Principal Investigator


Core A: Nanoparticle Development, Production, and Characterization

Core Investigator: Ian Baker, D.Phil.
This Core provides novel, well-characterized, biocompatible magnetic nanoparticles that can be heated in an alternating magnetic field to destroy tumors. The use of these nanoparticles is for breast cancer and ovarian cancer treatments, but the nanoparticles can potentially be used for any type of cancer.

Core B: Toxicology, Pathology, and Biodistribution

Core Investigator: Lionel D. Lewis, M.D.
This Core is designed to provide toxicology, pathology, and pharmacokinetic biodistribution support to the Dartmouth CCNE research projects. The primary goals of the Core are to aid Project investigators in identifying and understanding the effects and pharmacokinetic distribution of the various magnetic nanoparticles (mNPs) in plasma, tumors, and normal tissues (organs) at various times following their administration.

Core C: Biostatistics, Data Analysis, and Computation

Core Investigator: Eugene Demidenko, Ph.D.
This Core is involved in all aspects of magnetic nanoparticles (mNPs) production, characterization, implementation, and treatment outcomes assessment over the entire funding period. A comprehensive biostatistical analysis of the mNP-induced hyperthermia treatment outcomes in animal studies lays the foundation for its successful translation into clinic environment.